ENTX Appoints Geno J. Germano as Chairman, Aims to Advance EB613 and Other Oral Peptide Programs in 2026
Entera Bio Ltd. Ordinary Shares · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $1.27
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS